Monoamine oxidases in development
暂无分享,去创建一个
C. Ufer | H. Kuhn | E. Billett | A. Borchert | Chi-Chiu Wang
[1] M. Webster,et al. Developmental changes in human dopamine neurotransmission: cortical receptors and terminators , 2012, BMC Neuroscience.
[2] A. Mattevi,et al. The ‘gating’ residues Ile199 and Tyr326 in human monoamine oxidase B function in substrate and inhibitor recognition , 2011, The FEBS journal.
[3] R. Brigelius-Flohé,et al. Basic principles and emerging concepts in the redox control of transcription factors. , 2011, Antioxidants & redox signaling.
[4] P. F. Fitzpatrick,et al. Structures and mechanism of the monoamine oxidase family , 2011, Biomolecular concepts.
[5] Š. Čikoš,et al. Biogenic monoamines in preimplantation development. , 2011, Human reproduction.
[6] J. Doorn,et al. Inhibition and covalent modification of tyrosine hydroxylase by 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite. , 2011, Neurotoxicology.
[7] W. Severt,et al. Disease Modification in Parkinson’s Disease , 2011, Drugs & aging.
[8] J. Martinou,et al. Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. , 2011, Developmental cell.
[9] Roberta Menabò,et al. Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury. , 2011, Biochimica et biophysica acta.
[10] C. Ufer,et al. Monoamine Oxidase A Expression Is Vital for Embryonic Brain Development by Modulating Developmental Apoptosis* , 2011, The Journal of Biological Chemistry.
[11] J. Doorn,et al. Oxidation of 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopaminergic Metabolite, to a Semiquinone Radical and an ortho-Quinone* , 2011, The Journal of Biological Chemistry.
[12] J. Franklin. Redox regulation of the intrinsic pathway in neuronal apoptosis. , 2011, Antioxidants & redox signaling.
[13] M. Crair,et al. How do barrels form in somatosensory cortex? , 2011, Annals of the New York Academy of Sciences.
[14] W. A. van der Donk,et al. Cyclooxygenase reaction mechanism of prostaglandin H synthase from deuterium kinetic isotope effects. , 2011, Journal of inorganic biochemistry.
[15] J. Shih,et al. Transcriptional regulation and multiple functions of MAO genes , 2011, Journal of Neural Transmission.
[16] Per Svenningsson,et al. Modulation of monoamine receptors by adaptor proteins and lipid rafts: role in some effects of centrally acting drugs and therapeutic agents. , 2011, Annual review of pharmacology and toxicology.
[17] M. Norenberg,et al. Glutamine as a mediator of ammonia neurotoxicity: A critical appraisal. , 2010, Biochemical pharmacology.
[18] K. Mohanakumar,et al. 2-Phenylethylamine, a constituent of chocolate and wine, causes mitochondrial complex-I inhibition, generation of hydroxyl radicals and depletion of striatal biogenic amines leading to psycho-motor dysfunctions in Balb/c mice , 2010, Neurochemistry International.
[19] F. Turturro,et al. Troglitazone Regulates Anaplerosis via a Pull/Push Affect on Glutamate Dehydrogenase Mediated Glutamate Deamination in Kidney-derived Epithelial Cells; Implications for the Warburg Effect , 2010, Cellular Physiology and Biochemistry.
[20] M. Mattson,et al. Monoamine Oxidases Regulate Telencephalic Neural Progenitors in Late Embryonic and Early Postnatal Development , 2010, The Journal of Neuroscience.
[21] S. Rybárová,et al. Impact of 2 Doses of Clorgyline on the Rat Preimplantation Embryo Development and the Monoamine Levels in Urine , 2010, Reproductive Sciences.
[22] C. Ufer,et al. Redox control in mammalian embryo development. , 2010, Antioxidants & redox signaling.
[23] D. S. St. Clair,et al. Manganese superoxide dismutase versus p53: the mitochondrial center , 2010, Annals of the New York Academy of Sciences.
[24] K. Schulten,et al. O2 Reactivity of Flavoproteins , 2010, The Journal of Biological Chemistry.
[25] J. Fowler,et al. Identification and characterization of putative methylation targets in the MAOA locus using bioinformatic approaches , 2010, Epigenetics.
[26] O. Spigset,et al. Triptan Exposure During Pregnancy and the Risk of Major Congenital Malformations and Adverse Pregnancy Outcomes: Results From The Norwegian Mother and Child Cohort Study , 2010, Headache.
[27] K. Broadley. The vascular effects of trace amines and amphetamines. , 2010, Pharmacology & therapeutics.
[28] H. Forman,et al. Signaling functions of reactive oxygen species. , 2010, Biochemistry.
[29] P. Gaspar,et al. New perspectives on the neurodevelopmental effects of SSRIs. , 2010, Trends in pharmacological sciences.
[30] F. Artigas,et al. Unraveling monoamine receptors involved in the action of typical and atypical antipsychotics on glutamatergic and serotonergic transmission in prefrontal cortex. , 2010, Current pharmaceutical design.
[31] A. Parini,et al. Characterization of monoamine oxidases in mesenchymal stem cells: role in hydrogen peroxide generation and serotonin-dependent apoptosis. , 2010, Stem cells and development.
[32] D. Mousseau,et al. Serine 209 resides within a putative p38(MAPK) consensus motif and regulates monoamine oxidase‐A activity , 2009, Journal of neurochemistry.
[33] Amy L. Salisbury,et al. Fetal effects of psychoactive drugs. , 2009, Clinics in perinatology.
[34] L. Pollegioni,et al. Optimization of d‐amino acid oxidase for low substrate concentrations – towards a cancer enzyme therapy , 2009, The FEBS journal.
[35] J. Mallet,et al. Mammalian prenatal development: the influence of maternally derived molecules , 2009, BioEssays : news and reviews in molecular, cellular and developmental biology.
[36] Yun-Fai Chris Lau,et al. Regulation of monoamine oxidase A by the SRY gene on the Y chromosome , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[37] D. Mousseau,et al. Calcium alters monoamine oxidase-A parameters in human cerebellar and rat glial C6 cell extracts: possible influence by distinct signalling pathways. , 2009, Life sciences.
[38] A. Mattevi,et al. Molecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidases. , 2009, Biochemistry.
[39] X. Ou,et al. Retinoic Acid Activates Monoamine Oxidase B Promoter in Human Neuronal Cells* , 2009, The Journal of Biological Chemistry.
[40] L. Fattore,et al. The Roman High- and Low-Avoidance Rat Lines Differ in the Acquisition, Maintenance, Extinction, and Reinstatement of Intravenous Cocaine Self-Administration , 2009, Neuropsychopharmacology.
[41] O. Kellermann,et al. Computational approaches for the study of serotonin and its membrane transporter SERT: implications for drug design in neurological sciences. , 2008, Current medicinal chemistry.
[42] B. Casslén,et al. Monoamine transporters in human endometrium and decidua. , 2008, Human reproduction update.
[43] T. Lanthorn,et al. Genetic Disruption of Both Tryptophan Hydroxylase Genes Dramatically Reduces Serotonin and Affects Behavior in Models Sensitive to Antidepressants , 2008, PloS one.
[44] J. Shih,et al. Monoamine oxidase inactivation: from pathophysiology to therapeutics. , 2008, Advanced drug delivery reviews.
[45] S. Zanella,et al. Prenatal activation of 5‐HT2A receptor induces expression of 5‐HT1B receptor in phrenic motoneurons and alters the organization of their premotor network in newborn mice , 2008, The European journal of neuroscience.
[46] A. Witte,et al. The role of serotonin in intestinal luminal sensing and secretion , 2008, Acta physiologica.
[47] K. Haginoya,et al. β-Phenylethylamine Inhibits K+ Currents in Neocortical Neurons of the Rat: A Possible Mechanism of β-phenylethylamine-induced Seizures , 2008 .
[48] M. Smidt,et al. Modulation of Serotonin Transporter Function during Fetal Development Causes Dilated Heart Cardiomyopathy and Lifelong Behavioral Abnormalities , 2008, PloS one.
[49] I. Wierstra,et al. Sp1: emerging roles--beyond constitutive activation of TATA-less housekeeping genes. , 2008, Biochemical and biophysical research communications.
[50] R. Corradetti,et al. Sporadic Autonomic Dysregulation and Death Associated with Excessive Serotonin Autoinhibition , 2008, Science.
[51] C. Ufer,et al. Translational regulation of glutathione peroxidase 4 expression through guanine-rich sequence-binding factor 1 is essential for embryonic brain development. , 2008, Genes & development.
[52] Carol A. Mason,et al. Retinal axon growth at the optic chiasm: to cross or not to cross. , 2008, Annual review of neuroscience.
[53] M. Mareková,et al. Study of high deprenyl dose on the preimplantation embryo development and lymphocyte DNA in rat. , 2008, General physiology and biophysics.
[54] J. Shih,et al. Novel monoamine oxidase A knock out mice with human-like spontaneous mutation , 2008, Neuroreport.
[55] R. Chaerkady,et al. Serotonin in pre-implantation mouse embryos is localized to the mitochondria and can modulate mitochondrial potential. , 2008, Reproduction.
[56] E. Yamashita,et al. Structure of human monoamine oxidase A at 2.2-Å resolution: The control of opening the entry for substrates/inhibitors , 2008, Proceedings of the National Academy of Sciences.
[57] G. Desir,et al. Catecholamines Regulate the Activity, Secretion, and Synthesis of Renalase , 2008, Circulation.
[58] Dennis L. Murphy,et al. Targeting the murine serotonin transporter: insights into human neurobiology , 2008, Nature Reviews Neuroscience.
[59] J. Freed,et al. Determination of the oligomeric states of human and rat monoamine oxidases in the outer mitochondrial membrane and octyl beta-D-glucopyranoside micelles using pulsed dipolar electron spin resonance spectroscopy. , 2008, Biochemistry.
[60] C. Ufer,et al. Monoamine oxidase‐A modulates apoptotic cell death induced by staurosporine in human neuroblastoma cells , 2007, Journal of neurochemistry.
[61] N. Rasgon,et al. Mood disorders and fertility in women: a critical review of the literature and implications for future research. , 2007, Human reproduction update.
[62] Angelo Carotti,et al. Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs. , 2007, Journal of medicinal chemistry.
[63] W. Webster,et al. The effect of hypoxia in development. , 2007, Birth defects research. Part C, Embryo today : reviews.
[64] P. Pelicci,et al. Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals? , 2007, Nature Reviews Molecular Cell Biology.
[65] Hermann-Georg Holzhütter,et al. Molecular dioxygen enters the active site of 12/15-lipoxygenase via dynamic oxygen access channels , 2007, Proceedings of the National Academy of Sciences.
[66] Š. Čikoš,et al. Expression of adrenergic receptors in mouse preimplantation embryos and ovulated oocytes. , 2007, Reproduction.
[67] J. Mialet-Perez,et al. New insights on receptor-dependent and monoamine oxidase-dependent effects of serotonin in the heart , 2007, Journal of Neural Transmission.
[68] M. Blue,et al. Neonatal serotonin depletion alters behavioral responses to spatial change and novelty , 2007, Brain Research.
[69] P. Gaspar,et al. Developmental Cell Death Is Enhanced in the Cerebral Cortex of Mice Lacking the Brain Vesicular Monoamine Transporter , 2007, The Journal of Neuroscience.
[70] J. Mallet,et al. Maternal serotonin is crucial for murine embryonic development , 2007, Proceedings of the National Academy of Sciences.
[71] J. Hansen. Oxidative stress as a mechanism of teratogenesis. , 2006, Birth defects research. Part C, Embryo today : reviews.
[72] K. Itoh,et al. Substrate selectivity of monoamine oxidase A, monoamine oxidase B, diamine oxidase, and semicarbazide-sensitive amine oxidase in COS-1 expression systems. , 2006, Biological & pharmaceutical bulletin.
[73] L. Dwoskin,et al. Vesicular monoamine transporter 2: Role as a novel target for drug development , 2006, The AAPS Journal.
[74] H. Sørensen,et al. Maternal Use of Selective Serotonin Reuptake Inhibitors and Risk of Congenital Malformations , 2006, Epidemiology.
[75] N. Freemantle,et al. Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. , 2006, Archives of general psychiatry.
[76] Y. Larmet,et al. Unraveling in vivo Functions of Amyloid Precursor Protein: Insights from Knockout and Knockdown Studies , 2006, Neurodegenerative Diseases.
[77] R. Carroll,et al. Plasma serotonin in autism. , 2006, Pediatric neurology.
[78] X. Ou,et al. Monoamine oxidase A and repressor R1 are involved in apoptotic signaling pathway. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[79] M. Levin,et al. Of Minds and Embryos: Left-Right Asymmetry and the Serotonergic Controls of Pre-Neural Morphogenesis , 2006, Developmental Neuroscience.
[80] Mark Walker,et al. Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. , 2006, American journal of obstetrics and gynecology.
[81] B. Strassmann,et al. Cortisol levels and very early pregnancy loss in humans. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[82] S. Hernández-Díaz,et al. Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn , 2006, The New England journal of medicine.
[83] Sheldon Magder,et al. Reactive oxygen species: toxic molecules or spark of life? , 2006, Critical care.
[84] J. Greer,et al. Preparing for the first breath: prenatal maturation of respiratory neural control , 2006, The Journal of physiology.
[85] M. Morishima,et al. Monoamine Oxidase A Activity and Norepinephrine Level in Hippocampus Determine Hyperwheel Running in SPORTS Rats , 2006, Neuropsychopharmacology.
[86] R. Seger,et al. The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions , 2006, Growth factors.
[87] P. Amireault,et al. Intracellular cAMP and Calcium Signaling by Serotonin in Mouse Cumulus-Oocyte Complexes , 2005, Molecular Pharmacology.
[88] Andrea Mattevi,et al. Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[89] P. Amireault,et al. Serotonin and Its Antidepressant-Sensitive Transport in Mouse Cumulus-Oocyte Complexes and Early Embryos1 , 2005, Biology of reproduction.
[90] Yan A. Su,et al. Monoamine oxidase‐A is a major target gene for glucocorticoids in human skeletal muscle cells , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[91] H. Kuhn,et al. Expression regulation of MAO isoforms in monocytic cells in response to Th2 cytokines. , 2005, Medical science monitor : international medical journal of experimental and clinical research.
[92] Š. Čikoš,et al. Expression of beta adrenergic receptors in mouse oocytes and preimplantation embryos , 2005, Molecular reproduction and development.
[93] T. Einarson,et al. Antidepressant Use during Pregnancy and the Rates of Spontaneous Abortions: A Meta-Analysis , 2005, The Annals of pharmacotherapy.
[94] A. Mattevi,et al. Demonstration of Isoleucine 199 as a Structural Determinant for the Selective Inhibition of Human Monoamine Oxidase B by Specific Reversible Inhibitors* , 2005, Journal of Biological Chemistry.
[95] J. Gautier,et al. From oogenesis through gastrulation: developmental regulation of apoptosis. , 2005, Seminars in cell & developmental biology.
[96] S. Choi,et al. R1, a Novel Repressor of the Human Monoamine Oxidase A* , 2005, Journal of Biological Chemistry.
[97] J. Haavik,et al. Different properties of the central and peripheral forms of human tryptophan hydroxylase , 2005, Journal of neurochemistry.
[98] B. Gutiérrez,et al. Association analysis between a functional polymorphism in the monoamine oxidase A gene promoter and severe mood disorders , 2004, Psychiatric genetics.
[99] N. Scrutton. Chemical aspects of amine oxidation by flavoprotein enzymes. , 2004, Natural product reports.
[100] H. Lagercrantz,et al. Development of neurotransmitter systems during critical periods , 2004, Experimental Neurology.
[101] J. Fitzgerald,et al. Th2 Response of Human Peripheral Monocytes Involves Isoform-Specific Induction of Monoamine Oxidase-A12 , 2004, The Journal of Immunology.
[102] A. Doseff. Apoptosis: the sculptor of development. , 2004, Stem cells and development.
[103] J. Shih,et al. A Spontaneous Point Mutation Produces Monoamine Oxidase A/B Knock-out Mice with Greatly Elevated Monoamines and Anxiety-like Behavior*♦ , 2004, Journal of Biological Chemistry.
[104] Š. Čikoš,et al. Serotonin localization and its functional significance during mouse preimplantation embryo development , 2004, Zygote.
[105] L. Maffei,et al. ERK signaling is required for eye-specific retino-geniculate segregation , 2004, Development.
[106] A. Mattevi,et al. Structure and mechanism of monoamine oxidase. , 2004, Current medicinal chemistry.
[107] B. Levy,et al. Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. , 2004, The American journal of psychiatry.
[108] J. Mallet,et al. Recent advances in understanding serotonin regulation of cardiovascular function. , 2004, Trends in molecular medicine.
[109] S. Batalov,et al. A gene atlas of the mouse and human protein-encoding transcriptomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[110] Masato Yoshimura,et al. Structure of rat monoamine oxidase A and its specific recognitions for substrates and inhibitors. , 2004, Journal of molecular biology.
[111] A. Petros,et al. Structural biology of the Bcl-2 family of proteins. , 2004, Biochimica et biophysica acta.
[112] J. Medina,et al. Mitochondrial extracellular signal‐regulated kinases 1/2 (ERK1/2) are modulated during brain development , 2004, Journal of neurochemistry.
[113] P. Gaspar,et al. The developmental role of serotonin: news from mouse molecular genetics , 2003, Nature Reviews Neuroscience.
[114] V. Arango,et al. Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice , 2003, Biological Psychiatry.
[115] D. Murphy,et al. Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression , 2003, Biological Psychiatry.
[116] J. Mallet,et al. Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[117] M. Bader,et al. A unique central tryptophan hydroxylase isoform. , 2003, Biochemical pharmacology.
[118] W. K. Wong,et al. Decreased Methylation and Transcription Repressor Sp3 Up-regulated Human Monoamine Oxidase (MAO) B Expression during Caco-2 Differentiation* , 2003, Journal of Biological Chemistry.
[119] Andrea Mattevi,et al. Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[120] L. Altshuler,et al. Placental passage of antidepressant medications. , 2003, The American journal of psychiatry.
[121] D. Murphy,et al. Reduced programmed cell death in brains of serotonin transporter knockout mice , 2003, Neuroreport.
[122] T. Branchek,et al. Trace amine receptors as targets for novel therapeutics: legend, myth and fact. , 2003, Current opinion in pharmacology.
[123] H. Imai,et al. Biological significance of phospholipid hydroperoxide glutathione peroxidase (PHGPx, GPx4) in mammalian cells. , 2003, Free radical biology & medicine.
[124] N. Pellegrini,et al. Selected methodologies to assess oxidative/antioxidant status in vivo: a critical review. , 2002, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[125] Chi-Wai Wong,et al. Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[126] P. Gaspar,et al. Refinement of Thalamocortical Arbors and Emergence of Barrel Domains in the Primary Somatosensory Cortex: A Study of Normal and Monoamine Oxidase A Knock-Out Mice , 2002, The Journal of Neuroscience.
[127] Neal Castagnoli,et al. 8-(3-Chlorostyryl)caffeine May Attenuate MPTP Neurotoxicity through Dual Actions of Monoamine Oxidase Inhibition and A2A Receptor Antagonism* , 2002, The Journal of Biological Chemistry.
[128] D. Melton,et al. "Stemness": Transcriptional Profiling of Embryonic and Adult Stem Cells , 2002, Science.
[129] Wim E Crusio,et al. Knockout mice: simple solutions to the problems of genetic background and flanking genes , 2002, Trends in Neurosciences.
[130] Luciana Dini,et al. Cell death: apoptosis versus necrosis (review). , 2002, International journal of oncology.
[131] O. Kunduzova,et al. The FASEB Journal express article 10.1096/fj.01-1008fje. Published online May 21, 2002. Regulation of JNK/ERK activation, cell apoptosis, and , 2022 .
[132] W. K. Wong,et al. Activation of Human Monoamine Oxidase B Gene Expression by a Protein Kinase C MAPK Signal Transduction Pathway Involves c-Jun and Egr-1* , 2002, The Journal of Biological Chemistry.
[133] E. Billett,et al. Monoamine oxidase expression and activity in human placentae from pre-eclamptic and normotensive pregnancies. , 2002, Placenta.
[134] P. Gaspar,et al. Developmental expression of monoamine oxidases A and B in the central and peripheral nervous systems of the mouse , 2002, The Journal of comparative neurology.
[135] G. Killian,et al. Identification of norepinephrine in bovine oviductal fluid by high performance liquid chromatography. , 2001, Life Science.
[136] P. Berbel,et al. Role of thyroid hormones in the maturation and organisation of rat barrel cortex , 2001, Neuroscience.
[137] J. Raymond,et al. Multiplicity of mechanisms of serotonin receptor signal transduction. , 2001, Pharmacology & therapeutics.
[138] H. Lagercrantz,et al. Neurotransmitters and neuromodulators during early human development. , 2001, Early human development.
[139] G. Eisenhofer. The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. , 2001, Pharmacology & therapeutics.
[140] G. Buznikov,et al. Serotonin and serotonin-like substances as regulators of early embryogenesis and morphogenesis , 2001, Cell and Tissue Research.
[141] J. Bye,et al. Sequence analysis and transcript identification within 1.5 MB of DNA deleted together with the NDP and MAO genes in atypical Norrie disease patients presenting with a profound phenotype , 2001, Human mutation.
[142] K. Lesch,et al. Association analysis of the functional monoamine oxidase A gene promoter polymorphism in psychiatric disorders. , 2001, American journal of medical genetics.
[143] Dennis L. Murphy,et al. Excessive Activation of Serotonin (5-HT) 1B Receptors Disrupts the Formation of Sensory Maps in Monoamine Oxidase A and 5-HT Transporter Knock-Out Mice , 2001, The Journal of Neuroscience.
[144] D. Edmondson,et al. Structure-activity relations in the oxidation of phenethylamine analogues by recombinant human liver monoamine oxidase A. , 2000, Biochemistry.
[145] Hiroshi Nishimaru,et al. Formation of the central pattern generator for locomotion in the rat and mouse , 2000, Brain Research Bulletin.
[146] C. Culmsee,et al. Stimulation of 5-HT1A receptors reduces apoptosis after transient forebrain ischemia in the rat , 2000, Brain Research.
[147] D. Sorescu,et al. Modulation of Protein Kinase Activity and Gene Expression by Reactive Oxygen Species and Their Role in Vascular Physiology and Pathophysiology , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[148] A. Dierich,et al. Serotonin 2B receptor is required for heart development. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[149] J. Kauer,et al. Amphetamine Blocks Long-Term Synaptic Depression in the Ventral Tegmental Area , 2000, The Journal of Neuroscience.
[150] K. Davies,et al. Mitochondrial free radical generation, oxidative stress, and aging. , 2000, Free radical biology & medicine.
[151] S. Dey,et al. Blastocyst H(2) receptor is the target for uterine histamine in implantation in the mouse. , 2000, Development.
[152] I. Seif,et al. Abnormal Phrenic Motoneuron Activity and Morphology in Neonatal Monoamine Oxidase A-Deficient Transgenic Mice: Possible Role of a Serotonin Excess , 2000, The Journal of Neuroscience.
[153] A. Korten,et al. Association of a functional polymorphism of the monoamine oxidase A gene promoter with personality and psychiatric symptoms. , 2000, Psychiatric genetics.
[154] H. Lagercrantz,et al. Prenatal hypoxia impairs the postnatal development of neural and functional chemoafferent pathway in rat , 2000, The Journal of physiology.
[155] J. Cazalets,et al. Locomotor network maturation is transiently delayed in the MAOA-deficient mouse. , 2000, Journal of neurophysiology.
[156] G. Kirov,et al. A functional polymorphism in the promoter of monoamine oxidase A gene and bipolar affective disorder. , 1999, The international journal of neuropsychopharmacology.
[157] R. Palmiter,et al. Feeding behavior in dopamine-deficient mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[158] A. Giaccia,et al. Hypoxic microenvironment within an embryo induces apoptosis and is essential for proper morphological development. , 1999, Teratology.
[159] J. Leysen,et al. Does phenylethylamine act as an endogenous amphetamine in some patients? , 1999, The international journal of neuropsychopharmacology.
[160] P. Gaspar,et al. Excess of Serotonin (5-HT) Alters the Segregation of Ispilateral and Contralateral Retinal Projections in Monoamine Oxidase A Knock-Out Mice: Possible Role of 5-HT Uptake in Retinal Ganglion Cells During Development , 1999, The Journal of Neuroscience.
[161] M. Kung,et al. Ketanserin and tetrabenazine abolish aggression in mice lacking monoamine oxidase A , 1999, Brain Research.
[162] S. Nanko,et al. A functional polymorphism in the promoter region of monoamine oxidase-A gene and mood disorders , 1999, Molecular Psychiatry.
[163] O. Scremin,et al. Cerebral cortical blood flow maps are reorganized in MAOB-deficient mice , 1999, Brain Research.
[164] J. Isaac,et al. Experience-dependent development of NMDA receptor transmission , 1999, Nature Neuroscience.
[165] J. Parnavelas,et al. The noradrenergic system influences the fate of Cajal-Retzius cells in the developing cerebral cortex. , 1999, Brain research. Developmental brain research.
[166] G. Hilaire,et al. Serotonin levels are abnormally elevated in the fetus of the monoamine oxidase-A-deficient transgenic mouse , 1999, Neuroscience Letters.
[167] K. Okuda,et al. Noradrenaline stimulates the production of prostaglandin f2alpha in cultured bovine endometrial cells. , 1999, Biology of reproduction.
[168] T. Kundu,et al. CpG islands in chromatin organization and gene expression. , 1999, Journal of biochemistry.
[169] A. Porter,et al. Emerging roles of caspase-3 in apoptosis , 1999, Cell Death and Differentiation.
[170] D. Hamer,et al. A functional polymorphism in the monoamine oxidase A gene promoter , 1998, Human Genetics.
[171] S. Hansson,et al. Ontogeny of vesicular monoamine transporter mRNAs VMAT1 and VMAT2. II. Expression in neural crest derivatives and their target sites in the rat. , 1998, Brain research. Developmental brain research.
[172] P. Gaspar,et al. Plasma Membrane Transporters of Serotonin, Dopamine, and Norepinephrine Mediate Serotonin Accumulation in Atypical Locations in the Developing Brain of Monoamine Oxidase A Knock-Outs , 1998, The Journal of Neuroscience.
[173] R. Pendleton,et al. A new role for catecholamines: ontogenesis. , 1998, Trends in pharmacological sciences.
[174] N. Kudo,et al. Development of the spatial pattern of 5-HT-induced locomotor rhythm in the lumbar spinal cord of rat fetuses in vitro , 1998, Neuroscience Research.
[175] Fei Xu,et al. Knockout of the Vesicular Monoamine Transporter 2 Gene Results in Neonatal Death and Supersensitivity to Cocaine and Amphetamine , 1997, Neuron.
[176] Takeshi Kumazawa,et al. Increased stress response and β–phenylethylamine in MAOB–deficient mice , 1997, Nature Genetics.
[177] Christine F. Hohmann,et al. Behavioral consequences of abnormal cortical development: insights into developmental disabilities , 1997, Behavioural Brain Research.
[178] C. Adams,et al. D1 and D2Dopamine Receptors in Perinatal and Adult Basal Ganglia , 1997, Pediatric Research.
[179] M. Fanselow,et al. Selective enhancement of emotional, but not motor, learning in monoamine oxidase A-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[180] L. Zon,et al. Cdc42Hs, but Not Rac1, Inhibits Serum-stimulated Cell Cycle Progression at G1/S through a Mechanism Requiring p38/RK* , 1997, The Journal of Biological Chemistry.
[181] G. Cohen,et al. Parkinson disease: a new link between monoamine oxidase and mitochondrial electron flow. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[182] J. Padbury,et al. Human placental norepinephrine transporter mRNA: expression and correlation with fetal condition at birth. , 1997, Placenta.
[183] M. Weinstock. Does Prenatal Stress Impair Coping and Regulation of Hypothalamic-Pituitary-Adrenal Axis? , 1997, Neuroscience & Biobehavioral Reviews.
[184] G. Koren,et al. Neurodevelopment of children exposed in utero to antidepressant drugs , 1997, The New England journal of medicine.
[185] S. Stahl,et al. Mirtazapine: An Antidepressant with Noradrenergic and Specific Serotonergic Effects , 1997, Pharmacotherapy.
[186] T. Joh,et al. Localization of monoamine oxidase A and B mRNA in the rat brain by in situ hybridization , 1997, Synapse.
[187] P. Riederer,et al. Pharmacology of selegiline , 1996, Neurology.
[188] D. Broverman,et al. Individual differences in changes in mood and platelet monoamine oxidase (MAO) activity during hormonal replacement therapy in menopausal women , 1996, Psychoneuroendocrinology.
[189] L. Maroteaux,et al. Immunohistochemical localisation of the serotonin 5‐HT2B receptor in mouse gut, cardiovascular system, and brain , 1996, FEBS letters.
[190] P. Mastroiacovo,et al. The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Services (ENTIS). , 1996, Reproductive toxicology.
[191] V. Ganapathy,et al. Functional expression of the plasma membrane serotonin transporter but not the vesicular monoamine transporter in human placental trophoblasts and choriocarcinoma cells. , 1996, Placenta.
[192] A. Blaschke,et al. Widespread programmed cell death in proliferative and postmitotic regions of the fetal cerebral cortex. , 1996, Development.
[193] Qingbo Xu,et al. Activation of Mitogen-activated Protein Kinase by HO , 1996, The Journal of Biological Chemistry.
[194] J. Shih,et al. Influence of C Terminus on Monoamine Oxidase A and B Catalytic Activity , 1996, Journal of Neurochemistry.
[195] P. Malherbe,et al. Molecular neuroanatomy of human monoamine oxidases A and B revealed by quantitative enzyme radioautography and in situ hybridization histochemistry , 1996, Neuroscience.
[196] Patricia Gaspar,et al. Lack of Barrels in the Somatosensory Cortex of Monoamine Oxidase A–Deficient Mice: Role of a Serotonin Excess during the Critical Period , 1996, Neuron.
[197] R. Palmiter,et al. Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic , 1995, Cell.
[198] V. M. Pickel,et al. The vesicular monoamine transporter 2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[199] M. Subhash,et al. Monoamine oxidase isoenzymes in rat brain: Differential changes during postnatal development but not aging , 1995, Neurobiology of Aging.
[200] J. Launay,et al. Increased plasma serotonin in primary pulmonary hypertension. , 1995, The American journal of medicine.
[201] Puchkov Vf,et al. The effect of a serotonin deficiency on mammalian embryonic development , 1995 .
[202] J. Padbury,et al. Placental norepinephrine clearance: in vivo measurement and physiological role. , 1995, The American journal of physiology.
[203] P. Gaspar,et al. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. , 1995, Science.
[204] P. Malherbe,et al. Structure/function relationships of mitochondrial monoamine oxidase A and B chimeric forms. , 1995, European journal of biochemistry.
[205] R. Palmiter,et al. Noradrenaline is essential for mouse fetal development , 1995, Nature.
[206] E. Paykel,et al. Clinical efficacy of reversible and selective inhibitors of monoamine oxidase A in major depression , 1995, Acta psychiatrica Scandinavica. Supplementum.
[207] T. Slotkin,et al. Cocaine inhibits central noradrenergic and dopaminergic activity during the critical developmental period in which catecholamines influence cell development. , 1995, Brain research. Developmental brain research.
[208] J. Klinman,et al. Hydrogen tunneling in the flavoenzyme monoamine oxidase B. , 1994, Biochemistry.
[209] E. Scarr,et al. The effects of administration of monoamine oxidase‐B inhibitors on rat striatal neurone responses to dopamine , 1994, British journal of pharmacology.
[210] Yamamoto Ken-ichi,et al. Two different cellular redox systems regulate the DNA-binding activity of the p50 subunit of NF-κB in vitro , 1994 .
[211] D. Edmondson,et al. Structure-activity relationships in the oxidation of benzylamine analogues by bovine liver mitochondrial monoamine oxidase B. , 1994, Biochemistry.
[212] D. Glanzman. Postsynaptic regulation of the development and long-term plasticity of Aplysia sensorimotor synapses in cell culture. , 1994, Journal of neurobiology.
[213] G. Hilaire,et al. Involvement of the rostral ventro-lateral medulla in respiratory rhythm genesis during the peri-natal period: an in vitro study in newborn and fetal rats. , 1994, Brain research. Developmental brain research.
[214] B Fischer,et al. Oxygen tension in the oviduct and uterus of rhesus monkeys, hamsters and rabbits. , 1993, Journal of reproduction and fertility.
[215] M. Nelen,et al. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. , 1993, Science.
[216] U. Lang,et al. Systemic and uterine vascular response to serotonin in third trimester pregnant ewes. , 1993, European journal of obstetrics, gynecology, and reproductive biology.
[217] E. Sundström,et al. Neurochemical differentiation of human bulbospinal monoaminergic neurons during the first trimester. , 1993, Brain research. Developmental brain research.
[218] J. Shih,et al. The Deduced Amino Acid Sequences of Human Platelet and Frontal Cortex Monoamine Oxidase B Are Identical , 1993, Journal of neurochemistry.
[219] J. Lauder,et al. Neurotransmitters as growth regulatory signals: role of receptors and second messengers , 1993, Trends in Neurosciences.
[220] J. Lauder,et al. Serotonin and cardiac morphogenesis in the mouse embryo. , 1993, Teratology.
[221] J. Padbury,et al. Fetal catecholamine, cardiovascular, and neurobehavioral responses to cocaine. , 1992, American journal of obstetrics and gynecology.
[222] R. Blakely,et al. Expression of a cocaine-sensitive norepinephrine transporter in the human placental syncytiotrophoblast. , 1992, Biochemistry.
[223] E. Soriano,et al. Cell death and removal in the cerebral cortex during development , 1992, Progress in Neurobiology.
[224] X. Breakefield,et al. Structure of the human gene for monoamine oxidase type A. , 1991, Nucleic acids research.
[225] J. Shih,et al. Human monoamine oxidase A and B genes exhibit identical exon-intron organization. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[226] I. Seif,et al. Stable antiviral expression in BALB/c 3T3 cells carrying a beta interferon sequence behind a major histocompatibility complex promoter fragment , 1991, Journal of virology.
[227] R. Neve,et al. Tissue Distribution of Human Monoamine Oxidase A and B mRNA , 1990, Journal of neurochemistry.
[228] Markova Ln,et al. The effect of biogenic monoamine antagonists on the development of preimplantation mouse embryos cultured in vitro , 1990 .
[229] T. Kuroki,et al. [beta-Phenylethylamine and amphetamine: similar aspects in their behavioropharmacological and neurochemical characteristics]. , 1989, Yakubutsu, seishin, kodo = Japanese journal of psychopharmacology.
[230] R. Wiesner,et al. Oxygenation of mitochondrial membranes by the reticulocyte lipoxygenase. Action on monoamine oxidase activities A and B. , 1989, Biochimica et biophysica acta.
[231] J. Padbury. Functional maturation of the adrenal medulla and peripheral sympathetic nervous system. , 1989, Bailliere's clinical endocrinology and metabolism.
[232] N. Pratt,et al. Effects of social stress during early pregnancy on litter size and sex ratio in the golden hamster (Mesocricetus auratus). , 1989, Journal of reproduction and fertility.
[233] P. Chedrese,et al. The influence of ovarian hormones on the rat oviductal and uterine concentration of noradrenaline and 5-hydroxytryptamine , 1989, Neurochemical Research.
[234] T. Segawa,et al. [5-Hydroxytryptamine receptors]. , 1989, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.
[235] Acharya Sb,et al. Uterine and placental 5-HT profile in different gestational period of albino rats. , 1989 .
[236] A. Greenshaw,et al. Reciprocal changes in striatal dopamine and β-phenylethylamine induced by reserpine in the presence of monoamine oxidase inhibitors , 1988, Naunyn-Schmiedeberg's Archives of Pharmacology.
[237] R. M. Rose,et al. Localization of distinct monoamine oxidase a and monoamine oxidase b cell populations in human brainstem , 1988, Neuroscience.
[238] M. Youdim,et al. Platelet monoamine oxidase B: Use and misuse , 1988, Experientia.
[239] A. Colosimo,et al. A kinetic model for lipoxygenases based on experimental data with the lipoxygenase of reticulocytes. , 1987, European journal of biochemistry.
[240] W. Künzel,et al. Redistribution of fetal circulation during repeated asphyxia in sheep: effects on skin blood flow, transcutaneous PO2, and plasma catecholamines. , 1987, Journal of developmental physiology.
[241] M. Gimeno,et al. Catecholamines in sow graafian follicles at proestrus and at diestrus. , 1986, Biology of reproduction.
[242] A. Boulton,et al. Stereospecific deuterium substitution at the alpha-carbon position of dopamine and its effect on oxidative deamination catalyzed by MAO-A and MAO-B from different tissues. , 1986, Biochemical pharmacology.
[243] F. Gusovsky,et al. Clinical studies on the phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and phenylalanine dietary supplements. , 1986, The Journal of clinical psychiatry.
[244] Kiyofumi Kobayashi,et al. Developmental changes in the activity and substrate specificities of mouse brain monoamine oxidase , 1984, Neurochemical Research.
[245] J. Belmar,et al. Changes in noradrenergic vesicle markers of rabbit oviducts during progesterone treatment. , 1983, Biology of reproduction.
[246] R. Hammer,et al. Serotonin-induced disruption of implantation in the rat: II. Suppression of decidualization. , 1983, Biology of reproduction.
[247] W. Potter,et al. Temporal association between depression-dependent dyskinesias and high urinary phenylethylamine output. , 1983, Biological Psychiatry.
[248] G. S. Golden. A review of the neuroembryology of monoamine systems , 1982, Brain Research Bulletin.
[249] N. Sjöberg,et al. Regional and cyclic variations in catecholamine concentration of the human fallopian tube. , 1982, Biology of reproduction.
[250] C. Hobel,et al. Enzymes for epinephrine synthesis and metabolism in the myometrium, endometrium, red blood cells, and plasma of pregnant human subjects. , 1981, American journal of obstetrics and gynecology.
[251] M. Youdim,et al. ONTOGENESIS OF UPTAKE AND DEAMINATION OF 5‐HYDROXYTRYPTAMINE, DOPAMINE AND β‐PHENYLETHYLAMINE IN ISOLATED PERFUSED LUNG AND LUNG HOMOGENATES FROM RATS , 1981, British Journal of Pharmacology.
[252] J. Vliegenthart,et al. Double dioxygenation of arachidonic acid by soybean lipoxygenase-1. Kinetics and regio-stereo specificities of the reaction steps. , 1981, Biochimica et biophysica acta.
[253] M. Sandler,et al. Development of benzylamine oxidase and monoamine oxidase A and B in man. , 1980, Biochemical pharmacology.
[254] P. Bond,et al. Properties of monoamine oxidase (MAO) in human blood platelets, plasma, lymphocytes and granulocytes. , 1977, Clinica chimica acta; international journal of clinical chemistry.
[255] P. Patterson,et al. The induction of acetylcholine synthesis in primary cultures of dissociated rat sympathetic neurons. I. Effects of conditioned medium. , 1977, Developmental biology.
[256] C. S. Ramadoss,et al. Double dioxygenation of arachidonic acid by soybean lipoxygenase--1. , 1977, Biochemical and biophysical research communications.
[257] F. Bloom,et al. Ontogeny of monoamine neurons in the locus coeruleus, raphe nuclei and substantia nigra of the rat , 1975, The Journal of comparative neurology.
[258] Jackson Dm. Beta-phenylethylamine and locomotor activity in mice. Interaction with catecholaminergic neurones and receptors. , 1975 .
[259] B. Costall,et al. Dyskinetic phenomena caused by the intrastriatal injection of phenylethylamine, phenylpiperazine, tetrahydroisoquinoline and tetrahydronaphthalene derivatives in the guinea pig. , 1975, European journal of pharmacology.
[260] F. Bloom,et al. Ontogeny of monoamine neurons in the locus coeruleus, raphe nuclei and substantia nigra of the rat. I. Cell differentiation , 1974, The Journal of comparative neurology.
[261] C. Welker. Microelectrode delineation of fine grain somatotopic organization of (SmI) cerebral neocortex in albino rat. , 1971, Brain research.
[262] A. Weissman,et al. p-Chlorophenylalanine: a specific depletor of brain serotonin. , 1966, The Journal of pharmacology and experimental therapeutics.
[263] H. Blaschko,et al. The oxidation of adrenaline and other amines. , 1937, The Biochemical journal.
[264] Š. Alušík,et al. Serotonin syndrome. , 2014, Neuro endocrinology letters.
[265] M Pytliak,et al. Serotonin receptors - from molecular biology to clinical applications. , 2011, Physiological research.
[266] K. Haginoya,et al. Beta-phenylethylamine inhibits K+ currents in neocortical neurons of the rat: a possible mechanism of beta-phenylethylamine-induced seizures. , 2008, Tohoku journal of experimental medicine.
[267] W. Burke,et al. Aggregation of alpha-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine. , 2008, Acta neuropathologica.
[268] Jie Shen,et al. Gene-targeting technologies for the study of neurological disorders , 2007, NeuroMolecular Medicine.
[269] D. Wilhelm,et al. Sex determination and gonadal development in mammals. , 2007, Physiological reviews.
[270] C. Marsden,et al. Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease , 2005, Journal of Neural Transmission.
[271] E. Billett. Monoamine oxidase (MAO) in human peripheral tissues. , 2004, Neurotoxicology.
[272] T. Nagatsu. Progress in monoamine oxidase (MAO) research in relation to genetic engineering. , 2004, Neurotoxicology.
[273] H. Parvez,et al. Monoamine oxidase expression during development and aging. , 2004, Neurotoxicology.
[274] M. Grafe,et al. Transcriptional Regulation of the BCL-X Gene by NF-κB Is an Element of Hypoxic Responses in the Rat Brain , 2004, Neurochemical Research.
[275] M. Yamada,et al. Clinical pharmacology of MAO inhibitors: safety and future. , 2004, Neurotoxicology.
[276] J. Koppel,et al. Expression of serotonin receptors in mouse oocytes and preimplantation embryos. , 2003, Physiological research.
[277] Moussa B. H. Youdim,et al. Neuroprotective Strategies in Parkinson’s Disease , 2003, CNS drugs.
[278] Andrea Mattevi,et al. Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders , 2002, Nature Structural Biology.
[279] A. Parini,et al. Dopamine induces ERK activation in renal epithelial cells through H2O2 produced by monoamine oxidase. , 2001, Kidney international.
[280] J. Shih,et al. Monoamine oxidase: from genes to behavior. , 1999, Annual review of neuroscience.
[281] J. Padbury,et al. Placental biogenic amine transporters: in vivo function, regulation and pathobiological significance. , 1999, Placenta.
[282] J. Shih,et al. Increased stress response and beta-phenylethylamine in MAOB-deficient mice. , 1997, Nature genetics.
[283] J. Padbury,et al. The contribution of transporter-dependent uptake to fetal catecholamine clearance. , 1997, Biology of the neonate.
[284] G. Chouinard,et al. Moclobemide Update of its Pharmacological Properties and Therapeutic Use , 1996 .
[285] H. Lagercrantz,et al. Expression of c-fos, Tyrosine Hydroxylase, and Neuropeptide mRNA in the Rat Brain around Birth: Effects of Hypoxia and Hypothermia , 1995, Pediatric Research.
[286] H. Leese. Metabolic control during preimplantation mammalian development. , 1995, Human reproduction update.
[287] V. Otellin,et al. [The effect of a serotonin deficiency on mammalian embryonic development]. , 1995, Ontogenez.
[288] A. Cesura,et al. The role of monoamine oxidase and catechol O-methyltransferase in dopaminergic neurotransmission. , 1995, Journal of neural transmission. Supplementum.
[289] K. Mitomo,et al. Two different cellular redox systems regulate the DNA-binding activity of the p50 subunit of NF-kappa B in vitro. , 1994, Gene.
[290] D. Murphy,et al. Clinical, biochemical, and neuropsychiatric evaluation of a patient with a contiguous gene syndrome due to a microdeletion Xp11.3 including the Norrie disease locus and monoamine oxidase (MAOA and MAOB) genes. , 1992, American journal of medical genetics.
[291] L. Markova,et al. [The effect of biogenic monoamine antagonists on the development of preimplantation mouse embryos cultured in vitro]. , 1990, Zhurnal evoliutsionnoi biokhimii i fiziologii.
[292] A. Boulton,et al. Phenylethylamine in the CNS: effects of monoamine oxidase inhibiting drugs, deuterium substitution and lesions and its role in the neuromodulation of catecholaminergic neurotransmission. , 1990, Journal of neural transmission. Supplementum.
[293] S. Acharya,et al. Uterine and placental 5-HT profile in different gestational period of albino rats. , 1989, Indian journal of experimental biology.
[294] C. Thibault,et al. Catecholamines within the rabbit oviduct at fertilization time. , 1987, Human Reproduction.
[295] M. Youdim,et al. Monoamine oxidase B inhibition and the "cheese effect". , 1987, Journal of neural transmission. Supplementum.
[296] V. Rubio,et al. Human carbamoylphosphate synthetase I. , 1981, Enzyme.
[297] J. Lauder,et al. Roles for serotonin in neuroembryogenesis. , 1981, Advances in experimental medicine and biology.
[298] S. Potkin,et al. Phenylethylamine (PEA) and phenylacetic acid (PAA) in the urine of chronic schizophrenic patients and controls. , 1980, Psychopharmacology bulletin.
[299] Budantsev AIu,et al. [Effect of beta-phenylethylamine on the dopaminergic system of rat brain]. , 1979 .
[300] J. Lauder,et al. Serotonin as a differentiation signal in early neurogenesis. , 1978, Developmental neuroscience.
[301] C. Bachmann,et al. Enzymes of ammonia detoxication after portacaval shunt in the rat. I. Carbamylphosphate synthetase and aspartate transcarbamylase. , 1977, Enzyme.
[302] D. Jackson. Beta-phenylethylamine and locomotor activity in mice. Interaction with catecholaminergic neurones and receptors. , 1975, Arzneimittel-Forschung.
[303] V. Hamburger,et al. Prenatal development of spontaneous and evoked activity in the rat (Rattus norvegicus albinus). , 1971, Behaviour.